Abstract:
General managers (GMs) play a crucial role as enterprise leaders of the country affiliate of multi-national pharmaceutical companies, balancing needs, objectives and governance across all local functions. One such function, Medical Affairs, has undergone a significant evolution from a support function into a strategic partner and in some organizations a strategic leader supported by the increasing complexity of medications and a shift to more specialized medicines. Although the function has progressed significantly, there is opportunity to elevate Medical Affairs to another level, with GMs and business unit directors (BUDs) recommending increased business acumen, strategic approach, innovation and project management as competencies that could be further cultivated. Examining the current trends in the industry, including the increasing complexity of innovative medicines and patient journeys, a higher burden of evidence for the reimbursement of medicines, innovative data generation opportunities, the changing stakeholder engagement expectations and the focus on corporate reputation, Medical Affairs is positioned as a key to assist in navigating the organization through these complexities. The GM can help to foster the evolving role of Medical Affairs, encouraging lateral moves for broader enterprise mindset, imparting a culture of shared governance responsibilities across functions to encourage innovative thinking and nurture upcoming leaders by investing in training to take advantage of the above trends and deliver best patient and organizational outcomes now and in the future.
摘要:
总经理(GM)作为跨国制药公司的国家附属公司的企业领导人发挥着至关重要的作用,平衡需求,所有地方职能部门的目标和治理。一个这样的功能,医疗事务,已经经历了从支持职能到战略合作伙伴的重大演变,在一些组织中,战略领导者受到药物日益复杂和转向更专业药物的支持。虽然功能取得了显著进展,有机会将医疗事务提升到另一个水平,总经理和业务部门主管(BUD)建议提高商业敏锐度,战略方针,创新和项目管理作为可以进一步培养的能力。审视当前行业的发展趋势,包括创新药物和患者旅程的日益复杂,报销药品的证据负担更高,创新的数据生成机会,不断变化的利益相关者参与期望和对企业声誉的关注,医疗事务被定位为协助通过这些复杂性导航组织的关键。通用汽车可以帮助促进医疗事务的不断发展的作用,鼓励横向移动,以实现更广泛的企业心态,通过投资培训来利用上述趋势,并在现在和将来提供最佳的患者和组织成果,在各职能部门之间传授共同治理责任的文化,以鼓励创新思维并培养即将到来的领导者。